دوره 16، شماره 3 - ( 4-1404 )                   جلد 16 شماره 3 صفحات 499-493 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aboutorabi R B, Hariri G, Mazloum Khorasani Z, Mehrad-Majd H. The relationship between serum irisin levels and renal function in patients with type 2 diabetes mellitus. Caspian J Intern Med 2025; 16 (3) :493-499
URL: http://caspjim.com/article-1-4300-fa.html
The relationship between serum irisin levels and renal function in patients with type 2 diabetes mellitus. . 1404; 16 (3) :493-499

URL: http://caspjim.com/article-1-4300-fa.html


چکیده:   (92 مشاهده)
Background: Irisin, a myokine implicated in metabolic hemostasis, have been investigated in relation to type 2 diabetes mellitus (T2DM), yet findings on its serum levels and association with diabetic complications such as nephropathy remain inconsistent. This study aimed to assess the relationship between serum irisin levels and renal function in T2DM patients.
Methods: A cross-sectional study was conducted involving 140 individuals diagnosed with T2DM. Demographic, anthropometric, and clinical data were recorded. Fasting blood samples were collected to determine serum irisin levels using the ELISA method. Additional biochemical measurements included fasting blood glucose, creatinine, HDL, LDL, triglycerides, HbA1c, and urinary albumin. Correlations between irisin levels and these parameters were analyzed. Patients were divided into two groups based on glomerular filtration rate (GFR) and albumin-to-creatinine ratio (ACR) to assess associations between irisin levels and renal function.
Results: No statistically significant difference in serum irisin levels was observed between patients with reduced renal function (GFR≤60) and those with GFR>60 (10.45±6.54 vs. 13.32±10.59 ng/ml, P=0.08). In stratified analysis by ACR, patients with nephropathy displayed a non-significantly lower irisin level than those without (11.70±8.18 vs. 13.38±11.51, P=0.33). Serum irisin showed no significant correlations with FBS (P=0.05), insulin (P=0.06), LDL (P=0.96), HDL (P=0.61), or BMI (P=0.42).
Conclusion: Lower irisin levels in T2DM patients with reduced renal function or nephropathy may indicate a potential role for irisin in diabetic renal disease progression. Serum irisin could serve as a prognostic biomarker for diabetic nephropathy pending further validation.

 
متن کامل [PDF 378 kb]   (17 دریافت)    
نوع مطالعه: Original Article | موضوع مقاله: Nephrology
دریافت: 1402/12/10 | پذیرش: 1403/2/16 | انتشار: 1404/3/30

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Caspian Journal of Internal Medicine

Designed & Developed by : Yektaweb